Work

Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.

Year: 1998

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: P H Wiernik, J P Dutcher, A I Einzig, J Sparano, M Frank, W Friedenberg

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Yeshiva University, Marshfield Clinic, Marshfield Clinic, Marshfield Clinic

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: EASTERN COOPERATIVE ONCOLOGY GROUP, Cancer Center Support Grant

OpenAlex ID: W2415632741

FWCI: 1.407

Cites:

Cited by: 11

Related to: 10